Neuronetics

General Information
Business:

 

We are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.

 

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 67
Founded: 2003
Contact Information
Address 3222 Phoenixville Pike, Malvern, PA 19355, US
Phone Number (610) 640-4202
Web Address http://www.neurostar.com
View Prospectus: Neuronetics
Financial Information
Market Cap
Revenues $43.1 mil (last 12 months)
Net Income $-17.0 mil (last 12 months)
IPO Profile
Symbol STIM
Exchange NASDAQ
Shares (millions): 5.0
Price range $14.00 - $16.00
Est. $ Volume $75.0 mil
Manager / Joint Managers Piper Jaffray/ William Blair
CO-Managers Canaccord Genuity/ BTIG/ JMP Securities
Expected To Trade: 6/28/2018
Day: Thursday
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change